Show simple item record

dc.contributor.authorRulach, R.
dc.contributor.authorBall, D.
dc.contributor.authorChua, K. L. M.
dc.contributor.authorDahele, M.
dc.contributor.authorDe Ruysscher, D
dc.contributor.authorFranks, K.
dc.contributor.authorGomez, D.
dc.contributor.authorGuckenberger, M.
dc.contributor.authorHanna, G. G.
dc.contributor.authorLouie, A. V.
dc.contributor.authorMoghanaki, D.
dc.contributor.authorPalma, D. A.
dc.contributor.authorPeedell, C.
dc.contributor.authorSalem, Ahmed
dc.contributor.authorSiva, S.
dc.contributor.authorVidetic, G. M. M.
dc.contributor.authorChalmers, A. J.
dc.contributor.authorHarrow, S.
dc.date.accessioned2021-05-18T08:48:07Z
dc.date.available2021-05-18T08:48:07Z
dc.date.issued2021en
dc.identifier.citationRulach R, Ball D, Chua KLM, Dahele M, De Ruysscher D, Franks K, et al. An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer. Advances in Radiation Oncology. 2021 Mar;6(2):100653.en
dc.identifier.pmid33851065en
dc.identifier.doi10.1016/j.adro.2021.100653en
dc.identifier.urihttp://hdl.handle.net/10541/624012
dc.description.abstractPurpose: Thoracic reirradiation for non-small cell lung cancer with curative intent is potentially associated with severe toxicity. There are limited prospective data on the best method to deliver this treatment. We sought to develop expert consensus guidance on the safe practice of treating non-small cell lung cancer with radiation therapy in the setting of prior thoracic irradiation. Methods and materials: Twenty-one thoracic radiation oncologists were invited to participate in an international Delphi consensus process. Guideline statements were developed and refined during 4 rounds on the definition of reirradiation, selection of appropriate patients, pretreatment assessments, planning of radiation therapy, and cumulative dose constraints. Consensus was achieved once ≥75% of respondents agreed with a statement. Statements that did not reach consensus in the initial survey rounds were revised based on respondents' comments and re-presented in subsequent rounds. Results: Fifteen radiation oncologists participated in the 4 surveys between September 2019 and March 2020. The first 3 rounds had a 100% response rate, and the final round was completed by 93% of participants. Thirty-three out of 77 statements across all rounds achieved consensus. Key recommendations are as follows: (1) appropriate patients should have a good performance status and can have locally relapsed disease or second primary cancers, and there are no absolute lung function values that preclude reirradiation; (2) a full diagnostic workup should be performed in patients with suspected local recurrence and; (3) any reirradiation should be delivered using optimal image guidance and highly conformal techniques. In addition, consensus cumulative dose for the organs at risk in the thorax are described. Conclusions: These consensus statements provide practical guidance on appropriate patient selection for reirradiation, appropriate radiation therapy techniques, and cumulative dose constraints.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.adro.2021.100653en
dc.titleAn international expert survey on the indications and practice of radical thoracic reirradiation for non-small cell lung canceren
dc.typeArticleen
dc.contributor.departmentInstitute of Cancer Sciences, The University of Glasgow, Glasgowen
dc.identifier.journalAdvances in Radiation Oncologyen
dc.description.noteen
refterms.dateFOA2021-05-18T14:11:36Z


Files in this item

Thumbnail
Name:
33851065.pdf
Size:
384.7Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record